Blb&B Advisors, LLC Angion Biomedica Corp. Transaction History

Blb&B Advisors, LLC

  • $1.95 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 17, 2023
SELL
$0.8 - $1.0 $6,000 - $7,500
-7,500 Reduced 32.62%
15,495 $0
Q3 2022

Oct 14, 2022
SELL
$0.94 - $1.23 $31,820 - $41,637
-33,852 Reduced 59.55%
22,995 $21,000
Q2 2021

Jul 20, 2021
BUY
$13.02 - $17.83 $740,147 - $1.01 Million
56,847 New
56,847 $740,000

About Angion Biomedica Corp.

ANGN Quotes by TradingView
  • Ticker ANGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,113,300
  • Description
  • Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primaril...
More about ANGN
Track This Portfolio

Track Blb&B Advisors, LLC Portfolio

Follow Blb&B Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blb&B Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blb&B Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email